News

Jett Lawrence showed minimal movement between Rounds 1 and 2 of the 2025 Pro Motocross season, but intense competition with Eli Tomac last week narrowed the gap between the two favored riders. Jett ...
Eli Lilly is expanding its pain drug pipeline with the acquisition of SiteOne Therapeutics, a startup whose lead program addresses the same target as a Vertex Pharmaceuticals product whose ...
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally. The company offers Basaglar, Humalog, Humalog Mix 75/ ...
The latest price target for Eli Lilly (NYSE:LLY) was reported by UBS on May 2, 2025. The analyst firm set a price target for $1050.00 expecting LLY to rise to within 12 months (a possible 42.32% ...
Eli Lilly and Company (NYSE: LLY) today announced that data from studies of orforglipron, insulin efsitora alfa, tirzepatide (Zepbound and Mounjaro), retatrutide, eloralintide and bimagrumab will ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...
May 30, 2025: We checked for new Warframe codes. What are the new Warframe codes? If you're on the hunt for free glyphs and cosmetics, you're in luck – we've got a complete list of available ...